Cargando…

When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development

INTRODUCTION: The purpose of this study was to identify the key barriers to a customer-focused drug development process and develop a comprehensive framework to overcome them. METHODS: The paper draws on existing literature, both academic and practitioner, across a range of disciplines (innovation m...

Descripción completa

Detalles Bibliográficos
Autores principales: Oraiopoulos, Nektarios, Dunlop, William C. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504205/
https://www.ncbi.nlm.nih.gov/pubmed/28625003
http://dx.doi.org/10.1007/s12325-017-0567-y
_version_ 1783249239749427200
author Oraiopoulos, Nektarios
Dunlop, William C. N.
author_facet Oraiopoulos, Nektarios
Dunlop, William C. N.
author_sort Oraiopoulos, Nektarios
collection PubMed
description INTRODUCTION: The purpose of this study was to identify the key barriers to a customer-focused drug development process and develop a comprehensive framework to overcome them. METHODS: The paper draws on existing literature, both academic and practitioner, across a range of disciplines (innovation management, marketing, organizational behavior, behavioral economics, health economics, industry reports). On the basis of this extensive review, a conceptual framework is developed that offers concrete suggestions on how organizations can overcome the barriers and enable a more customer-focused development process. RESULTS: The barriers to collaboration are organized into three distinct categories (economic, behavioral, organizational), and within each category, a one-to-one mapping between barriers and solutions is developed. CONCLUSION: The framework is specifically designed with the objective of offering actionable and practical advice to executives who face these challenges in their organizations. The paper provides a unique theoretical contribution by synthesizing findings from several academic disciplines with concrete examples from the pharmaceutical industry. FUNDING: Mundipharma International Limited.
format Online
Article
Text
id pubmed-5504205
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-55042052017-07-25 When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development Oraiopoulos, Nektarios Dunlop, William C. N. Adv Ther Review INTRODUCTION: The purpose of this study was to identify the key barriers to a customer-focused drug development process and develop a comprehensive framework to overcome them. METHODS: The paper draws on existing literature, both academic and practitioner, across a range of disciplines (innovation management, marketing, organizational behavior, behavioral economics, health economics, industry reports). On the basis of this extensive review, a conceptual framework is developed that offers concrete suggestions on how organizations can overcome the barriers and enable a more customer-focused development process. RESULTS: The barriers to collaboration are organized into three distinct categories (economic, behavioral, organizational), and within each category, a one-to-one mapping between barriers and solutions is developed. CONCLUSION: The framework is specifically designed with the objective of offering actionable and practical advice to executives who face these challenges in their organizations. The paper provides a unique theoretical contribution by synthesizing findings from several academic disciplines with concrete examples from the pharmaceutical industry. FUNDING: Mundipharma International Limited. Springer Healthcare 2017-06-17 2017 /pmc/articles/PMC5504205/ /pubmed/28625003 http://dx.doi.org/10.1007/s12325-017-0567-y Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Oraiopoulos, Nektarios
Dunlop, William C. N.
When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development
title When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development
title_full When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development
title_fullStr When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development
title_full_unstemmed When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development
title_short When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development
title_sort when science is not enough: a framework towards more customer-focused drug development
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504205/
https://www.ncbi.nlm.nih.gov/pubmed/28625003
http://dx.doi.org/10.1007/s12325-017-0567-y
work_keys_str_mv AT oraiopoulosnektarios whenscienceisnotenoughaframeworktowardsmorecustomerfocuseddrugdevelopment
AT dunlopwilliamcn whenscienceisnotenoughaframeworktowardsmorecustomerfocuseddrugdevelopment